BSE filing, NSE: LINCOLN. Summary written from the filing by ALFA Finder's alert engine.
Lincoln Pharmaceuticals Ltd: key numbers
- Share price
- ₹508.00
- Market cap
- ₹1,018 Cr
- Revenue (annual)
- ₹671.0 Cr
- Net profit (annual)
- ₹87.89 Cr
- P/E (TTM)
- 10.5×Sector 46.1×
- Promoter holding
- 49.78%+0.00% QoQ
- FII holding
- 4.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lincoln Pharmaceuticals Ltd
All →Lincoln Pharmaceuticals Q2 FY27 Results: Net Profit ₹20.4 Cr, Up 2.0% YoY
Lincoln Pharmaceuticals Ltd reported revenue from operations of ₹191.3 Cr (+17.1% YoY) and net profit of ₹20.4 Cr (+2.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹20.4 Cr · +2.0% YoY
Lincoln Pharmaceuticals Board Meeting Date
Lincoln Pharmaceuticals intimated that its Board meeting is scheduled for 29 Oct 2026 to approve Q1/H1 2026 financial results. Trading window remains closed until 48 hours after results are published.
Lincoln Pharmaceuticals Other Announcement
Lincoln Pharmaceuticals Ltd has filed its quarterly shareholding pattern statement for the period ended September 30, 2026, as required under SEBI regulations.
Lincoln Pharmaceuticals Annual General Meeting
Lincoln Pharmaceuticals submitted the minutes and voting results of its 32nd Annual General Meeting held on September 30, 2026. The meeting concluded successfully.
Lincoln Pharmaceuticals Annual General Meeting
Lincoln Pharmaceuticals held its 32nd Annual General Meeting on September 30, 2026, where shareholders considered financial statements, dividends, and director reappointments.
Lincoln Pharmaceuticals Management Change
Lincoln Pharmaceuticals announced the resignation of Mr. Manoj Rai, Sr. General Manager (Head QA), a Senior Management Personnel. He departs effective 24 September 2026 for personal reasons.
Other management change announcements
All →Alldigi Tech Management Change
Alldigi Tech appointed Alok Kumar Chaubey as Vice President - Sales, effective 29 October 2026. He brings over 15 years of HR Tech SaaS experience.
Indegene Management Change
Indegene's Company Secretary and Compliance Officer Srishti Ramesh Kaushik resigned, effective 02-Dec-2026. The resignation cites future career advancement.
EPACK Durables Management Change
EPACK Durable's CFO, Rajesh Kumar Mittal, resigned citing personal reasons, effective October 31, 2026. The resignation was disclosed alongside board meeting outcomes held October 29, 2026.
Qualitek Labs Management Change
Qualitek Labs' Independent Director Ajay Agarwal resigned effective October 29, 2026, citing personal reasons. He was not on any board committee, so no reconstitution is required.
Ambani Orgochem Management Change
Ambani Orgochem announced the resignation of non-executive non-independent director Bhavin Patel, effective 29 October 2026. The resignation was attributed to professional priorities and commitments.
3i Infotech Management Change
3i Infotech appointed Shirsendu Chaudhuri as Chief Growth Officer, a senior management role, effective October 29, 2026. He brings over 22 years of experience in IT services, enterprise software and SaaS.